MLchartDataset catalogue

gamma-secretase/Notch signalling pathway inhibitor RO4929097

Term · Oncology and biomedicine · MLC-T-ONC-013897

An orally bioavailable, small-molecule gamma secretase (GS) inhibitor with potential antitumor activity. Gamma secretase inhibitor RO4929097 binds to GS and blocks activation of Notch receptors, which may inhibit tumor cell proliferation. The integral membrane protein GS is a multi-subunit protease complex that cleaves single-pass transmembrane proteins, such as Notch receptors, at residues within their transmembrane domains. Overexpression of the Notch signaling pathway has been correlated with increased tumor cell growth.

Table 1. Record
IdentifierMLC-T-ONC-013897
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013897",
  "term": "gamma-secretase/Notch signalling pathway inhibitor RO4929097",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable, small-molecule gamma secretase (GS) inhibitor with potential antitumor activity. Gamma secretase inhibitor RO4929097 binds to GS and blocks activation of Notch receptors, which may inhibit tumor cell proliferation. The integral membrane protein GS is a multi-subunit protease complex that cleaves single-pass transmembrane proteins, such as Notch receptors, at residues within their transmembrane domains. Overexpression of the Notch signaling pathway has been correlated with increased tumor cell growth.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/gamma-secretase-notch-signalling-pathway-inhibitor-ro4929097/"
}

Record 7,788 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.